Recurrence of hepatocellular cancer after resection: patterns, treatments, and prognosis.
By P. Tabrizian, G. Jibara, Brian Shrager, M. Schwartz, S. Roayaie. Annals of Surgery, 2015
805 citations recorded by the source corpus.
Subfields: Hepatology, Oncology, Surgery
View Paper: https://www.semanticscholar.org/paper/37e298459d2189cbcb6de3739233a76dd2296e9b
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Hepatology
- Amit G. Singal
- Andrew X. Zhu
- L. Kulik
- R. Finn
- Lewis R. Roberts
- Claude B. Sirlin
- J. Heimbach
- F. Kanwal
In Oncology
In Surgery
Citations in the corpus
- Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy (2023, background): “Although resection almost always results in complete removal of the initial tumour (or tumours), HCC recurrence is common (with 5-year rates of 50–70%), particularly in those with multi-nodular disease, microvascular invasion and/or poorly differentiated tumours 196”
- Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases (2019, background): “The risk of recurrence following resection is up to 70% at 5 years, with the most important predictors being tumor differentiation, micro- and macrovascular invasion, and the presence of satellite nodules.(115,116) Tumor size is not an independent predictor of recurrence, though increasing tumor siz”
- AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma (2023, neutral): “[162,194] Factors associated with recurrence include older age; male sex; degree of liver dysfunction; and tumor size, number, and grade/differentiation; microvascular and macrovascular invasion; presence of satellite lesions; and AFP level.”
- Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases (2018, background): “The risk of recurrence following resection is up to 70% at 5 years, with the most important predictors being tumor differentiation, micro- and macrovascular invasion, and the presence of satellite nodules.(115,116) Tumor size is not an independent predictor of recurrence, though increasing tumor siz”